PRAESIDIA

Praesidia is built with the vision of being a patient focused and clinician driven drug development company championing unmet clinical needs... Praesidia is a culmination of the two founders' over 50 years of combined drug development experience. This encompasses new target and new drug discovery, recombinant protein molecule and monoclonal antibody design, as well as platform development. The R&D experience extends to complete drug development lifecycle: from cell line to process development to scaling up to large scale GMP Manufacturing for clinical studies and market. Our experience and expertise are exponentially enriched by the scientific co-founders and expanding team of advisors with prominent academic, industrial and clinical pedigrees... Praesidia's corporate headquarters is in the greater Boston area that also manages the discovery phase of our pipeline. With our medicinal chemists in Toronto, Canada and process development (CMC) lab in Bangalore, India, we leverage the..

Primary location: Arlington United States